Suppr超能文献

增殖性疣状白斑前驱的口腔癌呈现出独特的分子特征。

Oral cancers preceded by proliferative verrucous leukoplakia exhibit distinctive molecular features.

机构信息

Department of Biotechnology, Universitat Politècnica de València, Valencia, Spain.

Centro de Investigación Biomédica en Red Cáncer, CIBERONC, Madrid, Spain.

出版信息

Oral Dis. 2024 Apr;30(3):1072-1083. doi: 10.1111/odi.14550. Epub 2023 Mar 21.

Abstract

OBJECTIVE

Proliferative verrucous leukoplakia (PVL) has high rates of malignant transformation into oral squamous cell carcinoma (OSCC), but the clinical and evolutionary pattern of OSCC from PVL (PVL-OSCC) is more favorable than that of OSCC not preceded by PVL (OSCC). Here, we aimed to explore the pathophysiologic differences between PVL-OSCC and OSCC through transcriptomic and DNA methylation analyses.

MATERIALS AND METHODS

In this case-control study, oral biopsies from 8 PVL-OSCC and 10 OSCC patients were obtained for global sequencing using RNAseq and a genome-wide DNA methylation analysis via the Infinium EPIC Platform (graphical abstract).

RESULTS

One hundred and thirty-three differentially expressed genes (DEGs) were detected, 94 of them upregulated in OSCC. Most of these genes were previously described in cancer and associated with prognosis. The integrative analysis revealed 26 DEGs, corresponding to 37 CpGs, whose promoters were regulated by DNA methylation. Twenty-nine of the CpGs were found as hypermethylated in PVL-OSCC. Only 5 of the genes that were aberrantly methylated and differentially expressed were upregulated in PVL-OSCC patients, whereas 21 were underexpressed.

CONCLUSIONS

PVL-OSCC patients presented lower expression of cancer-related genes. Hypermethylation of the promoter region of many genes was also noticed, indicating that DNA methylation could be a regulatory mechanism.

摘要

目的

增殖性疣状白斑(PVL)有很高的恶性转化为口腔鳞状细胞癌(OSCC)的风险,但PVL 前 OSCC(PVL-OSCC)的临床和进化模式比未被 PVL 前 OSCC(OSCC)更有利。在这里,我们旨在通过转录组和 DNA 甲基化分析来探讨 PVL-OSCC 和 OSCC 之间的病理生理差异。

材料和方法

在这项病例对照研究中,我们从 8 名 PVL-OSCC 和 10 名 OSCC 患者中获得了口腔活检组织,用于通过 RNAseq 进行全局测序和通过 Infinium EPIC 平台进行全基因组 DNA 甲基化分析(示意图)。

结果

检测到 133 个差异表达基因(DEGs),其中 94 个在 OSCC 中上调。这些基因中的大多数在癌症中已有描述,并与预后相关。综合分析发现 26 个 DEGs,对应于 37 个 CpG 位点,其启动子受 DNA 甲基化调控。在 PVL-OSCC 中发现 29 个 CpG 呈高甲基化。在 PVL-OSCC 患者中,仅有 5 个异常甲基化和差异表达的基因上调,而 21 个基因下调。

结论

PVL-OSCC 患者表现出更低的癌症相关基因表达。还注意到许多基因启动子区域的高甲基化,表明 DNA 甲基化可能是一种调节机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验